The molecular biology of cancer - PubMed (original) (raw)
Review
The molecular biology of cancer
J S Bertram. Mol Aspects Med. 2000 Dec.
Abstract
The process by which normal cells become progressively transformed to malignancy is now known to require the sequential acquisition of mutations which arise as a consequence of damage to the genome. This damage can be the result of endogenous processes such as errors in replication of DNA, the intrinsic chemical instability of certain DNA bases or from attack by free radicals generated during metabolism. DNA damage can also result from interactions with exogenous agents such as ionizing radiation, UV radiation and chemical carcinogens. Cells have evolved means to repair such damage, but for various reasons errors occur and permanent changes in the genome, mutations, are introduced. Some inactivating mutations occur in genes responsible for maintaining genomic integrity facilitating the acquisition of additional mutations. This review seeks first to identify sources of mutational damage so as to identify the basic causes of human cancer. Through an understanding of cause, prevention may be possible. The evolution of the normal cell to a malignant one involves processes by which genes involved in normal homeostatic mechanisms that control proliferation and cell death suffer mutational damage which results in the activation of genes stimulating proliferation or protection against cell death, the oncogenes, and the inactivation of genes which would normally inhibit proliferation, the tumor suppressor genes. Finally, having overcome normal controls on cell birth and cell death, an aspiring cancer cell faces two new challenges: it must overcome replicative senescence and become immortal and it must obtain adequate supplies of nutrients and oxygen to maintain this high rate of proliferation. This review examines the process of the sequential acquisition of mutations from the prospective of Darwinian evolution. Here, the fittest cell is one that survives to form a new population of genetically distinct cells, the tumor. This review does not attempt to be comprehensive but identifies key genes directly involved in carcinogenesis and demonstrates how mutations in these genes allow cells to circumvent cellular controls. This detailed understanding of the process of carcinogenesis at the molecular level has only been possible because of the advent of modern molecular biology. This new discipline, by precisely identifying the molecular basis of the differences between normal and malignant cells, has created novel opportunities and provided the means to specifically target these modified genes. Whenever possible this review highlights these opportunities and the attempts being made to generate novel, molecular based therapies against cancer. Successful use of these new therapies will rely upon a detailed knowledge of the genetic defects in individual tumors. The review concludes with a discussion of how the use of high throughput molecular arrays will allow the molecular pathologist/therapist to identify these defects and direct specific therapies to specific mutations.
Similar articles
- Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformation.
Coleman WB, Tsongalis GJ. Coleman WB, et al. Clin Chem. 1995 May;41(5):644-57. Clin Chem. 1995. PMID: 7729041 Review. - [Better understanding of the biology of cancer cells].
Klein G. Klein G. Ugeskr Laeger. 2000 Sep 25;162(39):5199-204. Ugeskr Laeger. 2000. PMID: 11043045 Review. Swedish. - [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
Tubiana M. Tubiana M. Cancer Radiother. 2009 Jul;13(4):238-58. doi: 10.1016/j.canrad.2009.03.003. Epub 2009 Jun 17. Cancer Radiother. 2009. PMID: 19539515 Review. French. - Molecular biology of colorectal cancer.
Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J. Gryfe R, et al. Curr Probl Cancer. 1997 Sep-Oct;21(5):233-300. doi: 10.1016/s0147-0272(97)80003-7. Curr Probl Cancer. 1997. PMID: 9438104 Review. - [Better understanding of the biology of cancer cells].
Klein G. Klein G. Lakartidningen. 2000 Jul 12;97(28-29):3260-4. Lakartidningen. 2000. PMID: 10997012 Review. Swedish.
Cited by
- Advancements in Understanding the Hide-and-Seek Strategy of Hibernating Breast Cancer Cells and Their Implications in Oncology from a Broader Perspective: A Comprehensive Overview.
Al-Ruwishan A, Amer B, Salem A, Abdi A, Chimpandu N, Esa A, Melemenis A, Saleem MZ, Mathew R, Gamallat Y. Al-Ruwishan A, et al. Curr Issues Mol Biol. 2024 Aug 1;46(8):8340-8367. doi: 10.3390/cimb46080492. Curr Issues Mol Biol. 2024. PMID: 39194709 Free PMC article. Review. - Lectins as a promising therapeutic agent for breast cancer: A review.
Singh K, Agrawal L, Gupta R, Singh D, Kathpalia M, Kaur N. Singh K, et al. Breast Dis. 2024;43(1):193-211. doi: 10.3233/BD-230047. Breast Dis. 2024. PMID: 38905027 Free PMC article. Review. - Multi-wall carbon Nanotube surface-based functional nanoparticles for stimuli-responsive dual pharmaceutical compound delivery.
Nabitabar M, Shaterian M, Danafar H, Enhessari M. Nabitabar M, et al. Sci Rep. 2024 May 27;14(1):12073. doi: 10.1038/s41598-024-59745-6. Sci Rep. 2024. PMID: 38802442 - Proteins Involved in Focal Cell Adhesion and Podosome Formation Are Differentially Expressed during Colorectal Tumorigenesis in AOM-Treated Rats.
Swain IX, Kresak AM. Swain IX, et al. Cancers (Basel). 2024 Apr 26;16(9):1678. doi: 10.3390/cancers16091678. Cancers (Basel). 2024. PMID: 38730628 Free PMC article. - Nanocomposite hydrogel microneedles: a theranostic toolbox for personalized medicine.
Martins CF, García-Astrain C, Conde J, Liz-Marzán LM. Martins CF, et al. Drug Deliv Transl Res. 2024 Aug;14(8):2262-2275. doi: 10.1007/s13346-024-01533-w. Epub 2024 Feb 20. Drug Deliv Transl Res. 2024. PMID: 38376619 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources